Siegfried Burggraf

Becker Technologies (Germany) — Germany

Biochemistry, Genetics and Molecular Biology · Life Sciences

32h-index4.8kcitations62works4.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Genomics and Phylogenetic Studies(21), Microbial Community Ecology and Physiology(18), Neurogenetic and Muscular Disorders Research(11), RNA modifications and cancer(8), Methane Hydrates and Related Phenomena(6)

Publications62 total

A Modular Genetic Approach to Newborn Screening from Spinal Muscular Atrophy to Sickle Cell Disease—Results from Six Years of Genetic Newborn Screening
Genes·2024· 7 citedOpen Access
Quality considerations and major pitfalls for high throughput DNA-based newborn screening for severe combined immunodeficiency and spinal muscular atrophy
PLoS ONE·2024· 1 citedOpen Access
High Throughput Newborn Screening for Sickle Cell Disease – Application of Two-Tiered Testing with a qPCR-Based Primary screen
Klinische Pädiatrie·2023· 8 citedOpen Access
Newbornscreening SMA – From Pilot Project to Nationwide Screening in Germany
Journal of Neuromuscular Diseases·2022· 37 citedOpen Access
Verification of lateral flow antigen tests for SARS-CoV-2 by qPCR directly from the test device
Dental Materials·2022· 5 citedOpen Access
Interpreting a covid-19 test result
Research Explorer (The University of Manchester)·2021
Newborn screening for spinal muscular atrophy in Germany: clinical results after 2 years
Orphanet Journal of Rare Diseases·2021· 158 citedOpen Access
Fast and cost-effective screening for SARS-CoV-2 variants in a routine diagnostic setting
Dental Materials·2021· 25 citedOpen Access
Newborn Screening for SMA - Results After Two Years of a Large Pilot Project 
Research Square (Research Square)·2020Open Access
Critical Questions when Interpreting Coronavirus PCR Diagnostics
2020Open Access
Fast and simple high-throughput testing of COVID 19
Dental Materials·2020· 9 citedOpen Access
Infants Diagnosed with Spinal Muscular Atrophy and 4 <i>SMN2</i> Copies through Newborn Screening – Opportunity or Burden?
Journal of Neuromuscular Diseases·2020· 66 citedOpen Access
Newborn Screening for SMA - Results after Two Years of a German Pilot Project
SSRN Electronic Journal·2020Open Access
Next generation sequencing as second-tier test in high-throughput newborn screening for nephropathic cystinosis
European Journal of Human Genetics·2019· 23 citedOpen Access
P.211Pilot study of genetic newborn screening for spinal muscular atrophy in Germany: clinical results after more than a year
Neuromuscular Disorders·2019
One Year of Newborn Screening for SMA – Results of a German Pilot Project
Journal of Neuromuscular Diseases·2019· 176 citedOpen Access
Molecular based newborn screening in Germany: Follow-up for cystinosis
Molecular Genetics and Metabolism Reports·2019· 40 citedOpen Access
High-throughput genetic newborn screening for spinal muscular atrophy by rapid nucleic acid extraction from dried blood spots and 384-well qPCR
European Journal of Human Genetics·2019· 58 citedOpen Access
Dendrite growth in undercooled Al-rich Al-Ni melts measured on Earth and in Space
Physical Review Materials·2019· 15 citedOpen Access
Lesson from hypomorphic recombination-activating gene (RAG) mutations: Why asymptomatic siblings should also be tested
Journal of Allergy and Clinical Immunology·2013· 33 cited
page 1 of 4Next →

Frequent Co-authors

Karl O. Stetter(19), Reinhard Rachel(12), Marc Becker(11), Bernhard Olgemöller(9), Jürgen Durner(9), Wulf Röschinger(8), Ludwig Czibere(8), Harald Huber(6), Carl R. Woese(6), Katharina Vill(6), Doris Hafenbradl(5), Uta Nennstiel(5), Brunhilde Wirth(5), Wolfgang Müller‐Felber(5), Siegfried Kösel(5), Holger W. Jannasch(4), Robert Huber(4), Reinhard Dirmeier(4), Thomas U. Mayer(4), Heike Kölbel(4)